.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing chronic ulcers requires an advanced diabetic wound healing membrane that can address prolonged inflammation. Diabetic foot ulcers remain a primary cause of morbidity in India due to hyperglycemia-induced cellular impairment. Consequently, researchers have focused on developing synthetic scaffolds that mimic the natural extracellular matrix to promote faster recovery.
A recently developed bi-layered membrane utilizes electrospun polycarbonate urethane (PCU) for the outer layer and gelatin for the inner layer. Specifically, the team crosslinked the gelatin side with alginate dialdehyde (ADA). This modification creates a unique niche that facilitates the migration and growth of repair cells. Furthermore, scanning electron microscopy confirmed that the fibrous characteristics of both polymers remained intact during the fabrication process. Notably, the trinitrobenzene sulphonic acid (TNBS) assay successfully validated the successful crosslinking of ADA to the gelatin base.
In addition to structural integrity, the membrane demonstrated exceptional fluid management properties. It achieved a water uptake of 243 ± 18% and a water vapor transmission rate of 620 g/m²/d. These metrics align perfectly with the requirements of commercially available high-end dressings. Moreover, the diabetic wound healing membrane showed superior biological efficacy. In a standard assay, the membrane achieved 44.7 ± 0.5% wound closure within just 8 hours. By comparison, the cell control group reached only 23.4 ± 3.6% closure in the same period. Therefore, this biomaterial appears to be highly cytocompatible and non-toxic for human tissue applications.
The ability to accelerate tissue repair is vital for preventing infections and subsequent amputations in diabetic patients. Thus, this fabricated membrane represents a potential breakthrough in diabetic wound care technology. Future studies will likely focus on in-vivo integration to confirm these preliminary in-vitro successes. However, the current data already suggests that this bi-layered approach could revolutionize how surgeons and endocrinologists manage hard-to-heal chronic wounds.
The membrane uses a bi-layered structure where the ADA-crosslinked gelatin acts as a scaffold. This encourages cell migration and growth, allowing tissue repair to start more quickly than traditional dressings.
The dressing consists of an outer layer of polycarbonate urethane (PCU) and an inner layer of gelatin crosslinked with alginate dialdehyde (ADA).
Initial cytocompatibility studies indicate that the membrane is non-toxic and supports high cell survival rates, though clinical trials in humans are still required.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Prathyusha undefined et al. Bi-layered polycarbonate urethane/alginate di-aldehyde crosslinked gelatin membrane as a potential biomaterial for wound healing applications. J Biomater Sci Polym Ed. 2026 Mar 22. doi: 10.1080/09205063.2026.2644608. PMID: 41865306.
Afjoul H, et al. Freeze-gelled Alginate/Gelatin Scaffolds for Wound Healing Applications: An In Vitro, In Vivo Study. Mater Sci Eng C Mater Biol Appl. 2020;113:110957.
Zhu Y, et al. A bi-layered scaffold of a poly(lactic-co-glycolic acid) nanofiber mat and an alginate-gelatin hydrogel for wound healing. J Mater Chem B. 2020;8:10300-10310.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new bi-layered PCU/gelatin membrane crosslinked with alginate dialdehyde shows 44.7% wound closure in 8 hours, offering a breakthrough for diabetic foot u...
7 months ago
Explore why official drug package inserts fail to reflect modern evidence for clozapine prescribing. Learn how legal standards of care, case law, slow titration, and vital adverse event monitoring empower clinicians to prioritize evidence-based medical practice over outdated manufacturer labeling.
Today
Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
